CRANK
发表于 2025-3-25 06:07:53
http://reply.papertrans.cn/67/6648/664778/664778_21.png
Predigest
发表于 2025-3-25 09:11:58
http://reply.papertrans.cn/67/6648/664778/664778_22.png
Temporal-Lobe
发表于 2025-3-25 13:19:44
New Oxazolidinone: Tedizolids approved for clinical use in the United States in 2000 and tedizolid was approved in 2014. Although resistance is rare to linezolid among gram-positive bacteria, tedizolid has greater potency, less frequent dosing, reduced hematological side effects, and less concern for monoamine oxidase inhibiti
催眠药
发表于 2025-3-25 18:00:35
New Tetracyclines: Eravacycline and Omadacyclinereased resistance, even to the semisynthetic second-generation compounds, doxycycline and minocycline, introduced in the 1960s–1970s. In the early 2000s, modification of the structure of minocycline led to the development of the third-generation, broader-spectrum tigecycline. Although effective agai
blight
发表于 2025-3-25 21:05:10
http://reply.papertrans.cn/67/6648/664778/664778_25.png
几何学家
发表于 2025-3-26 00:23:46
http://reply.papertrans.cn/67/6648/664778/664778_26.png
ineptitude
发表于 2025-3-26 07:05:01
New Systemic Antifungal: Isavuconazolene marrow transplantations, and autoimmune diseases. The need for new antifungal agents has arisen with the emergence of azole-resistant . species and multiresistant ., besides the shortcomings of existent agents. The azole class of agents is associated with potentially dangerous drug-drug interacti
Creditee
发表于 2025-3-26 10:37:10
http://reply.papertrans.cn/67/6648/664778/664778_28.png
的是兄弟
发表于 2025-3-26 13:53:09
New Antiretroviral Agents for HIV Infectionerapeutics. Once a death sentence, now HIV can be controlled with a single pill daily that result in lifespan almost the same as normal people. The advent of this triumph started with the development of potent combination therapy delivered in a single tablet or capsule, the first triple combination
断言
发表于 2025-3-26 17:21:25
http://reply.papertrans.cn/67/6648/664778/664778_30.png